Back to Search
RASHIDA ABBAS, MD
MD
Cardiovascular Disease Physician
NPI: 1811044605IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
28490(AL)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 1996
Research & Publications (16)
Polyethylene glycol modified-albumin enhances the cold preservation properties of University of Wisconsin solution in rat liver and a hepatocyte cell line.
PMID 19577257·J Surg Res·2010
7-preclinical
Development of a swine model of secondary liver tumor from a genetically induced swine fibroblast cell line.
PMID 18773055·HPB (Oxford)·2008
8-other
A phased-array stimulator system for studying planar and curved cardiac activation wavefronts.
PMID 18232365·IEEE Trans Biomed Eng·2008
8-other
In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoforms.
PMID 10889516·Hum Exp Toxicol·2000
8-other
Cardiotoxicity of Freon among refrigeration services workers: comparative cross-sectional study.
PMID 19594908·Environ Health·2009
8-other
Dynamics of glutathione and ophthalmate traced with 2H-enriched body water in rats and humans.
PMID 19401458·Am J Physiol Endocrinol Metab·2009
3-trial
A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors.
PMID 19318484·Clin Cancer Res·2009
3-trial
Disposition of desipramine, a sensitive cytochrome P450 2D6 substrate, when coadministered with intravenous temsirolimus.
PMID 19015855·Cancer Chemother Pharmacol·2009
3-trial
A phase I study of EKB-569 in combination with capecitabine in patients with advanced colorectal cancer.
PMID 18765554·Clin Cancer Res·2008
3-trial
Phase I pharmacokinetic/pharmacodynamic study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor tyrosine kinase, in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in first-line treatment of patients with metastatic colorectal cancer.
PMID 18172273·Clin Cancer Res·2008
3-trial
Pharmacokinetics, safety, and tolerability of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist after oral administration at single and multiple once-daily ascending doses in healthy volunteers.
PMID 15545307·J Clin Pharmacol·2004
3-trial
A novel per-oral insulin formulation: proof of concept study in non-diabetic subjects.
PMID 15049938·Diabet Med·2004
8-other
Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection.
PMID 12799572·AIDS·2003
5-case
Development and validation of a sensitive liquid chromatographic-tandem mass spectrometric method for the determination of cromolyn sodium in human plasma.
PMID 12668081·J Chromatogr B Analyt Technol Biomed Life Sci·2003
4-observational
Granulocyte colony-stimulating factor in a neutropenic infant with cervical lymphadenitis.
PMID 11430396·Ann Allergy Asthma Immunol·2001
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 930 FRANKLIN ST SE
HUNTSVILLE, AL 35801 - Phone
- (256) 539-4080
Quick Facts
- NPI
- 1811044605
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 16
Are you this provider?
Claim Your Profile